Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(7):894–903. doi: 10.1038/bjc.1997.481

An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours.

K O Hicks 1, S J Ohms 1, P L van Zijl 1, W A Denny 1, P J Hunter 1, W R Wilson 1
PMCID: PMC2228074  PMID: 9328149

Abstract

A new in vitro model has been developed for investigating extravascular diffusion of therapeutic agents in tumour tissue. V79-171b or EMT6/Ak cells are grown on porous Teflon support membranes and submerged in a large reservoir of medium, to give diffusion-limited 'multicellular membranes' (MMs) c. 200 microm in thickness. MMs are histologically similar to multicellular spheroids, but their planar rather than spherical geometry facilitates direct measurement of the flux of radiolabelled agents through the multicellular structure. For [14C]urea, flux kinetics through V79-171b MMs was modelled as simple diffusion, yielding a diffusion coefficient in the MM (DMM) of 1.45 x 10(-6) cm2 s(-1), 11-fold lower than in culture medium. Flux of the 3H-labelled DNA intercalator 9-[3-(N,N-dimethylamino)propylamino]acridine (DAPA) was dramatically slower than urea. Modelling this over the first 5 h gave a DMM of 1.3 x 10(-8) cm2 s(-1), but over longer times the kinetics was not consistent with simple diffusion. Flux of DAPA was markedly increased in the presence of 50 mM ammonium chloride, indicating that sequestration in acidic endosomes is a major impediment to flux. Accumulation in cytoplasmic vesicles was confirmed by fluorescence microscopy. The DAPA flux kinetics, with and without ammonium chloride, was well fitted by a reaction-diffusion model with reversible cellular uptake (modelled as binding), using uptake parameters determined in separate experiments with V79-171b single-cell suspensions. This study demonstrates the utility of the MM model for determining extravascular transport parameters, and indicates that much of the impediment to diffusion of basic DNA intercalators in tumour tissue may arise from lysosomal sequestration rather than DNA binding.

Full text

PDF
894

Images in this article

900Figure 7
on p.900

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adson A., Burton P. S., Raub T. J., Barsuhn C. L., Audus K. L., Ho N. F. Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. J Pharm Sci. 1995 Oct;84(10):1197–1204. doi: 10.1002/jps.2600841011. [DOI] [PubMed] [Google Scholar]
  2. Adson A., Raub T. J., Burton P. S., Barsuhn C. L., Hilgers A. R., Audus K. L., Ho N. F. Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. J Pharm Sci. 1994 Nov;83(11):1529–1536. doi: 10.1002/jps.2600831103. [DOI] [PubMed] [Google Scholar]
  3. Baguley B. C., Finlay G. J. Pharmacokinetic/cytokinetic principles in the chemotherapy of solid tumours. Clin Exp Pharmacol Physiol. 1995 Nov;22(11):825–828. doi: 10.1111/j.1440-1681.1995.tb01943.x. [DOI] [PubMed] [Google Scholar]
  4. Carlsson J., Acker H. Relations between pH, oxygen partial pressure and growth in cultured cell spheroids. Int J Cancer. 1988 Nov 15;42(5):715–720. doi: 10.1002/ijc.2910420515. [DOI] [PubMed] [Google Scholar]
  5. Casciari J. J., Hollingshead M. G., Alley M. C., Mayo J. G., Malspeis L., Miyauchi S., Grever M. R., Weinstein J. N. Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor model. J Natl Cancer Inst. 1994 Dec 21;86(24):1846–1852. doi: 10.1093/jnci/86.24.1846. [DOI] [PubMed] [Google Scholar]
  6. Clauss M. A., Jain R. K. Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues. Cancer Res. 1990 Jun 15;50(12):3487–3492. [PubMed] [Google Scholar]
  7. Cowan D. S., Hicks K. O., Wilson W. R. Multicellular membranes as an in vitro model for extravascular diffusion in tumours. Br J Cancer Suppl. 1996 Jul;27:S28–S31. [PMC free article] [PubMed] [Google Scholar]
  8. Durand R. E., Olive P. L. Evaluation of bioreductive drugs in multicell spheroids. Int J Radiat Oncol Biol Phys. 1992;22(4):689–692. doi: 10.1016/0360-3016(92)90504-b. [DOI] [PubMed] [Google Scholar]
  9. Durand R. E. Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage? Cancer Chemother Pharmacol. 1990;26(3):198–204. doi: 10.1007/BF02897199. [DOI] [PubMed] [Google Scholar]
  10. Groebe K., Erz S., Mueller-Klieser W. Glucose diffusion coefficients determined from concentration profiles in EMT6 tumor spheroids incubated in radioactively labeled L-glucose. Adv Exp Med Biol. 1994;361:619–625. doi: 10.1007/978-1-4615-1875-4_114. [DOI] [PubMed] [Google Scholar]
  11. Hoffman R. M. Three-dimensional histoculture: origins and applications in cancer research. Cancer Cells. 1991 Mar;3(3):86–92. [PubMed] [Google Scholar]
  12. Jain R. K., Baxter L. T. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res. 1988 Dec 15;48(24 Pt 1):7022–7032. [PubMed] [Google Scholar]
  13. Jain R. K. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987 Jun 15;47(12):3039–3051. [PubMed] [Google Scholar]
  14. Kerr D. J., Kaye S. B. Aspects of cytotoxic drug penetration, with particular reference to anthracyclines. Cancer Chemother Pharmacol. 1987;19(1):1–5. doi: 10.1007/BF00296245. [DOI] [PubMed] [Google Scholar]
  15. Kwok T. T., Twentyman P. R. Use of a tritiated thymidine suicide technique in the study of the cytotoxic drug response of cells located at different depths within multicellular spheroids. Br J Cancer. 1987 Apr;55(4):367–374. doi: 10.1038/bjc.1987.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leys E. J., Crouse G. F., Kellems R. E. Dihydrofolate reductase gene expression in cultured mouse cells is regulated by transcript stabilization in the nucleus. J Cell Biol. 1984 Jul;99(1 Pt 1):180–187. doi: 10.1083/jcb.99.1.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Minchinton A. I., Wendt K. R., Clow K. A., Fryer K. H. Multilayers of cells growing on a permeable support. An in vitro tumour model. Acta Oncol. 1997;36(1):13–16. doi: 10.3109/02841869709100724. [DOI] [PubMed] [Google Scholar]
  18. Nederman T., Carlsson J., Malmqvist M. Penetration of substances into tumor tissue--a methodological study on cellular spheroids. In Vitro. 1981 Apr;17(4):290–298. doi: 10.1007/BF02618140. [DOI] [PubMed] [Google Scholar]
  19. Olive P. L. Patterns of mutagen binding and penetration in multicell spheroids. Environ Mutagen. 1986;8(5):705–715. doi: 10.1002/em.2860080506. [DOI] [PubMed] [Google Scholar]
  20. Peck C. C., Beal S. L., Sheiner L. B., Nichols A. I. Extended least squares nonlinear regression: a possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic data. J Pharmacokinet Biopharm. 1984 Oct;12(5):545–558. doi: 10.1007/BF01060132. [DOI] [PubMed] [Google Scholar]
  21. Roberts P. B., Denny W. A., Wakelin L. P., Anderson R. F., Wilson W. R. Radiosensitization of mammalian cells in vitro by nitroacridines. Radiat Res. 1990 Aug;123(2):153–164. [PubMed] [Google Scholar]
  22. Safranyos R. G., Caveney S., Miller J. G., Petersen N. O. Relative roles of gap junction channels and cytoplasm in cell-to-cell diffusion of fluorescent tracers. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2272–2276. doi: 10.1073/pnas.84.8.2272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Siim B. G., Denny W. A., Wilson W. R. Does DNA targeting affect the cytotoxicity and cell uptake of basic nitroquinoline bioreductive drugs? Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):311–315. doi: 10.1016/0360-3016(94)90281-x. [DOI] [PubMed] [Google Scholar]
  24. Sutherland R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 1988 Apr 8;240(4849):177–184. doi: 10.1126/science.2451290. [DOI] [PubMed] [Google Scholar]
  25. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989 Dec 1;49(23):6449–6465. [PubMed] [Google Scholar]
  26. Vistica D. T. Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell. Biochim Biophys Acta. 1979 Jan 19;550(2):309–317. doi: 10.1016/0005-2736(79)90217-7. [DOI] [PubMed] [Google Scholar]
  27. Wilson W. R., Denny W. A., Pullen S. M., Thompson K. M., Li A. E., Patterson L. H., Lee H. H. Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N. Br J Cancer Suppl. 1996 Jul;27:S43–S47. [PMC free article] [PubMed] [Google Scholar]
  28. Wilson W. R., Denny W. A., Stewart G. M., Fenn A., Probert J. C. Reductive metabolism and hypoxia-selective toxicity of nitracrine. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1235–1238. doi: 10.1016/0360-3016(86)90266-x. [DOI] [PubMed] [Google Scholar]
  29. Wilson W. R., Whitmore G. F., Hill R. P. Activity of 4'-(9-acridinylamino)methanesulfon-m-anisidide against Chinese hamster cells in multicellular spheroids. Cancer Res. 1981 Jul;41(7):2817–2822. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES